Bringing the fundamentals into focus…
Back to The Oncology Institute, Inc.
How The Oncology Institute, Inc. stacks up
STLN · against 588 other Healthcare companies listed in US-listed
Valuation
75/ 100
Near the top of its peers.
Ranked #62 of 589 · scores higher than 88% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 70–79, including STLN · Click a bar to see the companies
Why valuation scores 75?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -2.8% vs peer median 4.0%
- lower earnings for the price paid: weaker than 72% of peers. Earnings yield: 9383.3% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.5% vs peer median 0.0%
Metric by metric
Position: dot = STLN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -4.6% | -4.3% | 49% | 30% | |
| EBITDA yieldHigher is better · 578 reported | -2.7% | -0.8% | 45% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | -0.5% | -2.3% | 57% | 20% | |
| Book yieldHigher is better · 587 reported | -3.9% | 25.9% | 7% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around STLN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 62 | 1.8B USD | 75 | 80 | |
| 62 | 107M USD | 75 | 31 | |
| 62 | 2.7B USD | 75 | 84 | |
| 62 | 464M USD | 75 | 53 | |
| 62 | 646M USD | 75 | 46 | |
| 62 | 1.2B USD | 75 | ||
| 62 | 314M USD | 75 | 56 | |
| 71 | 63.0B USD | 74 | 65 | |
| 71 | 36.4B USD | 74 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score